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Abstract
Quality assurance (QA) is the process of providing evidence that the outcome meets the 
established standards. Quality improvement (QI), by contrast, is the act of methodically 
developing ways to meet acceptable quality standards and evaluating current processes to improve 
overall performance. In the case of the National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP), the desired outcome is the delivery of quality health care services to 
program clients. The NBCCEDP provides professional development to ensure that participating 
providers have current knowledge of evidence-based clinical standards regarding breast and 
cervical cancer screening and diagnosis and are monitoring women with abnormal screening 
results for timely follow-up. To assess the quality of clinical care provided to NBCCEDP clients, 
performance data are collected by NBCCEDP grantees and compared against predetermined 
Centers for Disease Control and Prevention (CDC) benchmarks known as Data Quality Indicator 
Guides. In this article, the authors describe 1) the development and use of indicators for QI in the 
NBCCEDP and 2) the professional development activities implemented to improve clinical 
outcomes. QA identifies problems, whereas QI systematically corrects them. The quality of 
service delivery and improved patient outcomes among NBCCEDP grantees has enhanced 
significantly because of continuous monitoring of performance and professional development. By 
using QA, NBCCEDP grantees can maximize the quality of patient screening, diagnostic services, 
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and follow-up. Examples of grantee activities to maintain quality of care are also described in this 
report.
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INTRODUCTION
Since the mid-1990s, the Institute of Medicine (IOM) has addressed the quality of healthcare 
in the United States. The IOM established a committee called the National Roundtable on 
Health Care Quality, which was charged to identify issues and provide recommendations 
related to improving the quality of health care across the nation.1 In 1990, the IOM defined 
quality care as the degree to which health services for individuals and populations increase 
the likelihood of desired health outcomes and are consistent with current professional 
knowledge.2 On the basis of that definition, they identified 3 major problems with health 
care: 1) excessive, unnecessary, or inappropriate care; 2) under-use of needed, effective, and 
appropriate care; and 3) errors and negligence in care. From that report, it was concluded 
that measuring the quality of health care is needed to identify the problems and provide 
solutions that improve health and prevent harm. Quality assurance (QA) is the process of 
providing evidence that the outcome meets established standards. Quality improvement 
(QI), by contrast, is the act of methodically developing ways to meet acceptable quality 
standards and evaluating current processes to improve overall performance.3,4 QA identifies 
problems, and QI systematically corrects them. Consequently, many health agencies began 
to develop quality measures and to implement continuous QI efforts.
When drafting the public law that authorized the National Breast and Cervical Cancer Early 
Detection Program (NBCCEDP), the US Congress wanted to ensure that quality standards 
were maintained for all clinical services provided to women enrolled in the program. The 
Breast and Cervical Cancer Mortality Prevention Act (Public Law 101-354) states that all 
NBCCEDP grantees shall have access to mechanisms through which they “can monitor the 
quality of screening procedures for breast and cervical cancer, including the interpretation of 
such procedures.5” Therefore, since the inception of the NBCCEDP, QA and QI were 
incorporated as integral components of program performance. Before developing and 
implementing QI activities, 4 quality principles were implemented.6
The program must:
1. Identify and meet the needs of patients, their families, and providers;
2. Understand the systems and processes encountered by patients moving through the 
medical system as they receive care and the processes by which clinical decisions 
are made;
3. Assure that appropriate stakeholders are committed and vested in quality outcomes; 
and
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4. Collect data to identify problems/barriers and measure program performance.
From these principles, key performance standards and QI efforts were established. QI 
involves assessing the level of program performance, implementing improvements based on 
that assessment, and monitoring the improvements made. QI allows flexibility for grantees 
to conduct specific activities that aim to:
• Identify and resolve root causes of quality problems;
• Identify process steps for meeting quality standards;
• Improve efficiency of services provided;
• Identify and meet the needs of clients; and
• Ensure cost-effective program performance.
The law also mandates that professional development services be included as an integral part 
of the program. It describes this function as activities “to improve the education, training, 
and skills of health professionals (including allied health professionals) in the detection and 
control of breast and cervical cancer.”5 Funds must be available to ensure that the care 
provided to program clients is evidence based using the most current information. 
Educational efforts are directed toward all patient care providers participating in the Breast 
and Cervical Cancer Control Program to ensure quality of the health care services. This 
includes mammography technicians, radiologists, nurse practitioners, registered nurses, case 
managers, clinical nurse midwives, physician assistants, pathologists, laboratory technicians, 
obstetricians/gynecologists, internists, family practitioners, and adolescent medicine 
physicians as well as providers’ non-clinical staff who are responsible for duties such as 
patient enrollment, scheduling, and referrals to specialists.7
In this article, we discuss mechanisms of QA through both QI and professional development 
in the NBCCEDP and demonstrate how these mechanisms are evaluated to determine 
overall success. We also provide 4 grantee examples of activities implemented to achieve 
QI.
Using Performance Standards for QI
Because the NBCCEDP grantees are mandated by public law to plan and implement QA 
activities that evaluate health services provided to clients, a set of Minimal Data Elements 
(MDEs) were developed to be used by grantees to ensure the collection of data components 
for measuring the quality of clinical care.8 The data collected include screening examination 
dates and results, information on whether or not further diagnostic testing is planned, what 
type of diagnostic testing is required, final diagnoses, and initiation of treatment if cancer is 
diagnosed. These data are reported on all women to the NBCCEDP grantees by the 
providers at the point of screening. Data are then consolidated and submitted biannually to 
the Centers for Disease Control and Prevention (CDC). Each grantee’s aggregated MDE 
data are compared against a set of performance indicators developed by the Centers for 
Disease Control and Prevention (CDC) known as data-quality indicator guides (DQIGs) 
(Table 1). The DQIGs assist grantees with monitoring completion of the screening process, 
the provision of appropriate clinical services, and the timeliness of diagnosis and treatment. 
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A subset of 11 DQIGs (identified by the NBCCEDP as core performance indicators) is used 
to monitor the quality of key breast and cervical cancer clinical care services—timeliness of 
final diagnosis after an abnormal screening result and completeness of care. A grantee’s 
performance is based on meeting the predetermined performance standard for each 
indicator. The linkage of data quality and quality of clinical care delivered are intertwined in 
a 2-way relation that helps to ensure that women enrolled in the NBCCEDP are receiving 
quality and timely follow-up care.
The CDC provides DQIG feedback reports to grantees with a summary indicating whether 
their performance meets program performance standards. This report is used by the grantees, 
as well as the CDC, to identify key areas of quality concern for intervention. In response, 
many grantees initiate internal QI monitoring activities to target the key performance areas 
identified for improvement. These activities have resulted in performance improvement in 
areas such as the percentage of clients with abnormal screening results who have complete 
diagnostic follow-up and the percentage with a cancer diagnosis that have initiated 
treatment.9 To reward excellence and efficiency for program performance, the CDC 
developed a performance-based funding process. This process, which was first implemented 
in 2004, involves the CDC rating each grantee’s performance based on the core performance 
indicators. Programs considered “high performers,” are eligible for modest budget increases 
if funds are available. In contrast, “low performers,” may receive no budget increase or may 
have budget reductions. Linking program performance to funding awarded to grantees by 
the CDC has resulted in a steady improvement in the number of grantees meeting the DQIG 
performance standards. For more details, see the article by DeGroff et al in this 
supplement.10
Grantees incorporated QI strategies as they developed, implemented, and evaluated 
procedures, practice guidelines, treatment protocols, and expected health care outcomes for 
all clients. Quality has improved measurably among the CDC’s 68 grantees as measured by 
meeting the performance standards of the DQIGs.10 Before 2004, aggregate data for all 
grantees indicated that only 7 of 10 core performance standards were met. However, after 
implementing the performance-based funding process, grantees are meeting all 10 standards. 
An example is depicted in Figure 1, illustrating the change over time in the percentage of 
breast and cervical cancer abnormal screening results that have had complete diagnostic 
follow-up. Therefore, performance-based funding seems to have provided a stimulus for 
implementing QI in all aspects of program performance.
Grantees use the performance standards for both prospective and retrospective program 
evaluation.11 Prospective use includes tracking the current screening status of a woman to 
promote regular rescreening and prompts to providers about results still pending. This real-
time use of data allows case managers to intervene (if needed) to facilitate timely and 
complete care. Retrospective use allows grantees to assess what has already occurred and to 
identify overall program trends. Reviewing retrospective data provides opportunities to 
improve practice patterns of individual providers, evaluate the types of clinical services 
performed for the patient, and assess whether an improvement made was the result of a QI 
activity.
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Using the DQIG feedback reports, the CDC has also been able to assess the feasibility and 
usefulness of these performance standards. For example, the standard for the time from an 
abnormal cervical screening result to diagnosis was initially 60 days. Despite numerous 
interventions by grantees, the 60-day standard had been difficult to meet for various reasons, 
such as limited availability of colposcopy providers that resulted in increased wait times for 
colposcopy appointments, the rescheduling of appointments, and delays in the referral of 
women with abnormal Papanicolaou (Pap) tests from external sources into the NBCCEDP 
for diagnostic evaluation. In 2009, the CDC noted that this performance standard was 
established based on the best clinical judgment and standards of care at the time it was 
developed and that, in the absence of new scientific data suggesting otherwise, the standard 
could be revised. Therefore, the timeliness standard was modified from 60 days to 90 days 
for the time from abnormal Pap test results to diagnosis. This change demonstrates how 
monitoring the quality of clinical care was used to revise the performance standard for a 
quality indicator.
Each grantee implements QA/QI activities to meet the unique needs of their program and 
health care delivery system. Some grantees manage all of their QI activities centrally, 
whereas other grantees decentralize their QA activities and have contractors monitor and 
intervene on quality concerns at a regional level. All grantees prioritize their QA activities 
by using DQIG data to identify problems and monitor trends in performance. It has been 
most effective in evaluating both what was done (adherence to benchmarks, standards, 
protocols, etc) and how it was done (process of delivering services).
Professional Development/Education
Providers participating in the NBCCEDP are expected to provide patient care consistent 
with professional clinical recommendations and NBCCEDP policies. However, guidelines 
are only useful to the extent that they are adopted and routinely used by providers. Over the 
years, the focus of professional development has evolved from developing and 
implementing clinical program guidelines and policies and conducting training (breast and 
cervical cancer epidemiology, clinical updates, cancer screening, and diagnostic testing) to 
placing greater emphasis on effectively disseminating this information. In recent years, the 
focus of the CDC has been on evidence-based interventions that increase breast and cervical 
cancer screening, as recommended by the Guide to Community Preventive Services,12 and 
developing the capacity to use evidenced-based techniques, such as academic detailing,13 to 
deliver education and training to program providers. By using research-proven methods, 
grantees are better able to improve clinical practice and increase screening rates. 
Compliance with the national program’s clinical and performance policies are required in a 
grantee’s provider contracts.
To assess the actual practice of professional development in the NBCCEDP, in October 
2007, Dr. Cam Escoffery and colleagues at the Emory University Rollins School of Public 
Health conducted an inventory of the NBCCEDP interventions. The purpose of that study 
was to provide an overview of professional development activities being implemented by 
grantees and to assess the extent to which these activities were based on evidence-based 
strategies.14
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In total, 252 professional development activities were reported. Among the grantees, 59% 
reported using conferences such as workshops, lectures, and grand rounds; 49% reported 
using educational materials such as tool kits, manuals, Web sites, and training videos or 
webcasts; 23% used educational outreach/academic detailing; 12% used audit and feedback 
reports; 10% used local opinion leaders; and 7% used organizational activities (Table 2). 
Some grantees (29%) reported using multi-component activities. The objectives for the 
professional development activities reported by the grantees included: to increase provider 
knowledge (72%), change provider performance (51%), change provider attitudes (46%), 
and increase the number of women recruited into the program (44%). When deciding which 
topics to address for professional development activities, the top 3 reasons reported were 
CDC’s policy change (93%), questions from providers (88%), and findings from the DQIG 
reports (80%).
Programs reported that they perceived the most effective professional development activities 
to be conferences (34%), trainings (24%), educational materials (22%), meetings (12%), 
speakers (7%), updates (7%), and technical assistance (7%). Whereas it has been 
demonstrated that conferences and workshops are some of the least effective methods of 
changing provider behavior,15 it has been demonstrated that audit and feedback,16 provider 
reminders,17 and academic detailing13,18,19 are more effective strategies. These methods 
offer unique opportunities for providers to deliver the best care for their patients in a 
complex and rapidly changing medical world.
State Grantee Activities
Michigan—Improving clinical and data quality—The Michigan Breast and Cervical 
Cancer Control Program (MBCCCP) operates in 20 county/regional health departments and 
at 1 cancer institute. Breast and cervical screening and diagnostic services are provided to 
approximately 24,000 women each year by more than 700 participating health care 
providers. The 21 agencies operating the program are responsible for contracting with 
providers in their service delivery area to provide the MBCCCP clinical services to women 
enrolled in the program. The MDE data are entered by the local agencies into a state-wide, 
Web-based system, the Michigan Breast and Cervical Cancer Control Information System.
In 1999, the MBCCCP was failing to meet several DQIG core performance standards. Staff 
at the Michigan Department of Community Health observed that records in the database did 
not accurately reflect the quality of clinical services being provided to MBCCCP clients. 
Documentation of clinical services in the statewide data-base was inconsistent and often 
incomplete compared with the medical record. The MBCCCP clinical and data staff 
collaborated with the Michigan Peer Review Organization to develop processes that 
addressed clinical protocols and MDE reporting, and they assisted local agencies in 
understanding the interaction between delivery of care and proper recording of data that 
accurately reflected that care. Regional workshops, called clinical problem-solving sessions, 
were developed for both clinicians and data staff that demonstrated the linkage between 
clinical care delivery and DQIGs. These sessions gave local and state staff the opportunity to 
work together in identifying potential solutions to problems and interventions that could be 
implemented to improve their agency’s processes. In addition to these workshops, Michigan 
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instituted telephone and in-person consultations by state staff and developed clinical data 
reports for local staff to highlight areas in which performance standards were not met.
Data and clinical staff joined forces and began to understand the complexities and learn the 
language of each other’s domain. Staff began to work as a team to determine whether the 
quality issues were data driven, clinically driven, or both. This team approach allowed 
Michigan to build a strong foundation for QI. Michigan began its team approach by 
clarifying terminology into standard language and creating clinical and data algorithms to 
follow the medical standards of care. Both clinical staff and data staff used these algorithms 
to translate clinical care delivery to data requirements with an emphasis on the accurate 
documentation of care. All of the measures taken as part of the QA/QI program in Michigan 
have resulted in a reduction in data errors, increased adherence to the medical guidelines, 
and reduction in the average cost per woman for direct clinical services. Michigan continues 
to strive toward excellence in data quality, clinical care delivery, and responsible 
stewardship of program funds. Over the past several years, Michigan has consistently met all 
of the DQIG core performance standards.
Louisiana—Improving quality care—The Louisiana Breast and Cervical Health 
Program (LBCHP) provides breast and cervical cancer screening and diagnostic services 
through public and private healthcare providers. LBCHP provides screening services to 
about 13,000 women each year in the state of Louisiana. In 2006, the LBCHP determined 
that it had failed to meet the performance standards for the cervical cancer screening 
timeliness indicator of obtaining a final diagnosis after an abnormal screening Pap test 
result. At that time, the indicator standard was <60 days from the date of abnormal 
screening. After a review of their MDE data, they were able to identify all cases that had not 
met the standard. The providers who performed the Pap test for each of the cases were 
requested to review their cases and provide details on why there was a delay in obtaining a 
final diagnosis. It was noted that 1 LBCHP clinic disproportionately contributed to the 
number of untimely diagnoses. Internal review indicated that the delays to final diagnosis 
were caused by repeated missed appointments. In many of these cases, the client missed up 
to 6 scheduled appointments. The LBCHP services coordinator then contacted these women 
to determine the reasons. They observed that women either did not comprehend the need for 
follow-up or were afraid.
The LBCHP staff began to work closely with the provider clinics to monitor all high-grade, 
abnormal Pap test results. For each scheduled follow-up appointment, the client received a 
reminder call about her appointment 1 or 2 days before the appointment. The client was 
asked whether she had any barriers to attending the appointment (eg, not being able to get 
time off work, not having transportation, not being able to get child care, etc). The provider 
also made an extra effort to explain the Pap test finding and why showing up for the 
appointment and completing the diagnostic evaluation was so important. The day before the 
appointment, the client was called again to remind her of her appointment and to ask 
whether she would have any barriers or needed help making her appointment. If a barrier 
was identified, then the provider contacted the LBCHP services coordinator for assistance. 
LBCHP has been able to provide assistance such as gas cards to clients when providers 
identified this as a need.
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Since implementation of this intervention, LBCHP has been able to consistently meet the 
standard for this cervical cancer screening indicator. LBCHP continues to monitor each 
abnormal Pap test result. The providers continue to make reminder calls to the clients and 
identify whether there are any barriers to making the scheduled appointments. LBCHP has 
had no further problems meeting their goal. The average length of time from abnormal 
screening result to final diagnosis in the LBCHP is now 55 days.
South Carolina—Office detailing—South Carolina’s program, the Best Chance 
Network (BCN), provides services through contracts with a statewide network of over 200 
providers with at least 1 in each of the state’s 46 counties. The American Cancer Society has 
managed the service coordination, professional development, and outreach and recruitment 
components of the BCN since 1995 through a contract with South Carolina Department of 
Health and Environmental Control. Professional development is an integral component of 
the BCN and provides a continuum of training opportunities that were developed to assure 
optimal service delivery. Regional Service Coordinators provide hands-on guidance and on-
site professional education to provider practices, often going beyond clinical instruction to 
assisting the practices to better serve the patient and improve office operations.
The BCN Professional Development Manager designs and revises educational materials to 
reflect the needs identified by the program’s data, thus assuring consistency with the quality-
of-care guidelines from the NBCCEDP policy. Fashioned after office detailing (or academic 
detailing), 15 presentations are given by the Regional Service Coordinators to providers at 
their individual office settings with dates and times that accommodate providers’ schedules. 
Currently, there are 2 professional development programs available to BCN providers, and 
both offer continuing education (CE) credits. Orientation to the Best Chance Network 
Program (1.5 CE credits) is a mandatory presentation for all new providers and their staff. 
Each new provider is given the Best Chance Network Provider Manual, a comprehensive 
guidebook that covers eligibility requirements, clinical guidelines, program procedures, 
forms completion, scheduling, screening and follow-up, and billing and reimbursement 
procedures. The second program offered by BCN is Professional Education for Best Chance 
Network Providers. This educational program (1 CE credit) includes up-to-date statistical 
information on breast and cervical cancer, recommended screening guidelines, follow-up of 
abnormal breast and cervical findings, and the importance of cultural sensitivity.
From 1991 to 1995, a centralized model of education delivery was used but was identified as 
ineffective, with fewer than 100 providers and staff attending the centralized seminars. Since 
1996, professional development has been provided through on-site offerings in provider 
offices. Approximately 458 providers received on-site training in the first year, and greater 
than 8359 individuals have attended on-site professional development programs since its 
implementation. This on-site strategy has proven to be a cost-effective and efficient way to 
educate and update providers.
Kentucky: Web-based learning program—The state of Kentucky has 120 counties 
and is geographically diverse. The Kentucky Department for Public Health is made up of 41 
independent local county health departments and 15 district health departments. To enhance 
the learning process for clinicians, the Kentucky Women’s Cancer Screening Program 
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(KWCSP) contracted with the Kentucky Cancer Program at the University of Louisville to 
develop Web-based learning modules for its providers. These modules educate providers on 
evidence-based clinical screening practices used by the KWCSP. The modules are also used 
to train nurse case managers in local Health Departments who conduct day-to-day quality-
assurance activities, contact patients with results, and schedule appropriate follow-up to the 
test results. The modules promote continuity of case management and clinical service 
delivery across the state.
The Kentucky Cancer Program has also developed 3 modules for the use of health care 
providers in the community. One module introduces physicians and their staff to the 
KWCSP and the Breast and Cervical Cancer Treatment Program, and 2 modules provide 
information on how to identify and effectively outreach to women who have never or rarely 
been screened for breast and cervical cancer.
The platform used for the Web-based modules is the Kentucky Training-Finder Real-Time 
Affiliate Integrated Network (TRAIN) program. These modules are also available for use by 
private health care providers in Kentucky to increase their use of the KWCSP and the Breast 
and Cervical Cancer Treatment Program. Continuing medical education credit is provided 
for Kentucky physicians through a collaborative agreement between the Kentucky Cancer 
Program and the Kentucky Medical Association. The Kentucky Cancer Program promotes 
the TRAIN modules to physicians, nurse practitioners, physician assistants, and registered 
nurses through presentations at state-wide professional meetings, journal articles, Web 
postings, direct mailings, etc.
Conclusion
Improving quality in the delivery of health care services is a complicated endeavor that 
continues to evolve. A growing body of evidence indicates that certain QI processes are 
associated with better clinical outcomes. Measures taken to ensure that clients receive timely 
and appropriate screening and diagnostic services and timely treatment services are critical 
components in reducing cancer mortality.9 In the current health care environment, the 
importance of integrating both QI measures and professional development into cancer 
screening programs is recommended. Thus, as the health care system undergoes a 
reconfiguration, NBCCEDP grantees will be challenged to implement improvement 
processes that balance the effective and efficient delivery of quality care while experiencing 
shrinking financial resources.
CDC grantees have established program operations to meet their unique needs and, for the 
past 20 years, have implemented various QA approaches and techniques. The most program 
successes have been validated through the evaluation of both what is done (adherence to 
benchmarks, standards, protocols, etc) and how it is done (process of delivering services). 
To provide QI, NBCCEDP grantees must: 1) identify quality issues using data, 2) determine 
the causes of the issues (data driven or clinically driven), and 3) develop effective program 
monitoring and improvement processes to rectify those issues. In addition, to ensure that the 
most appropriate, high-quality care is being provided, professional development/education 
activities should be designed to educate providers on the science that supports the clinical 
guidelines and protocols. It is imperative that programs separate data issues from clinical 
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care issues to help ensure that women enrolled in the NBCCEDP are receiving the best care 
possible. The CDC will continue to support and encourage the use of QI and professional 
development activities by grantees as part of their QA.
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Completeness indicators for the data-quality indicator guides are measured as the percentage 
of abnormal breast and cervical cancer screening results that had complete diagnostic 
follow-up: the National Breast and Cervical Cancer Early Detection Program standard is 
≥90% of abnormal screens. PY indicates program year.
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TABLE 1
National Breast and Cervical Cancer Early Detection Program Core Performance Indicators and Standards
Core Performance Indicator Performance
Standard, %
Breast cancer
   Abnormal screening results with complete follow-upa ≥90
   Time from abnormal screening results to a final diagnosis >60 d ≤ 25
   Treatment started for breast cancera ≥90
   Time from diagnosis of breast cancer to start of treatment >60 d ≤20
Cervical cancer
   Abnormal screening results with complete follow-upa ≥90
   Time from abnormal screening results to a final diagnosis >90 d ≤ 25
   Treatment started for diagnosis of HSIL, CIN2, CIN3, CIS, invasive carcinomaa ≥90
   Time from diagnosis of HSIL, CIN2, CIN3, or CIS to treatment >90 d ≤20
   Time from final diagnosis of invasive carcinoma to start of treatment >60 d ≤20
Abbreviations: CIN, cervical intraepithelial neoplasia; CIS, carcinoma in situ; HSIL, high-grade squamous intraepithelial neoplasia.
a
This indicator is not measured until about 9 months postscreening for both breast and cervical cancer.
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TABLE 2
Reported Professional Development Activities Used by National Breast and Cervical Cancer Early Detection 
Program Grantees
Types of Activities No. of
Grantees (%)a
Conferences 148 (59)
Educational materials 124 (49.4)
Educational outreach/academic detailing 57 (22.7)
Audit and feedback 29 (11.6)
Local opinion leader 26 (10.4)
Organizational interventions 17 (6.8)
Provider incentives 10 (4)
Provider reminders 9 (3.6)
Multicomponent activities 74 (29.4)
aActivities are not mutually exclusive; therefore, percentages will not total 100%.
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